A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
UF Health Hospitals Rely on Green Globes to Realize Their Full Potential
How Healthcare Facilities Can Be Truly Disaster-Resilient
TriasMD Breaks Ground on DISC Surgery Center for San Fernando Valley
Bigfork Valley Hospital Falls Victim to Data Breach
AI-Driven Facilities: Strategic Planning and Cost Management